What Researchers Did
Researchers reported a case of severe exercise-induced rhabdomyolysis in a 22-year-old male who had consumed a synephrine-containing weight-loss dietary supplement.
What They Found
The patient experienced severe rhabdomyolysis, reaching a peak creatine phosphokinase level of 2.8 million U/L, complicated by acute renal failure, pulmonary edema, and compartment syndromes. He required extensive hospitalization, including hemodialysis and multiple surgeries, and sustained permanent neurological deficits in his lower extremities.
What This Means for Canadian Patients
Canadian patients should be aware of the potential severe risks associated with weight-loss dietary supplements, especially those containing synephrine. It is crucial for patients to discuss all supplements with their healthcare providers and prioritize healthy lifestyle changes for weight management.
Canadian Relevance
This study has no direct Canadian connection as it is a case report from the US military.
Study Limitations
As a single case report, the findings cannot be generalized to the broader population.